[Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
Kurbanov
R D
RD
D000157:Aconitine / Q000009:adverse effects / Q000031:analogs & derivatives; D000638:Amiodarone / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D004206:Disopyramide / Q000009:adverse effects; D004562:Electrocardiography; D006801:Humans; D016293:Moricizine / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D010640:Phenothiazines; D016293:Moricizine; C051402:allapinin; D011433:Propranolol; C046818:ethacizine; D004206:Disopyramide; D011342:Procainamide; D000638:Amiodarone; D000157:Aconitine
Sravnitel'naia kharakteristika aritmogennogo deĭstviia antiaritmicheskikh preparatov.